World
Covid Antibodies Endure Over Six Months in China Trial Subjects
- Top scientist projected confidence over vaccine effectiveness
- China to produce 1 billion doses by end of 2021, official says
Photographer: Roy Liu/Bloomberg
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
The amount of Covid-19 antibodies in trial subjects who received China’s experimental vaccines remained high six months after the first shots, said a top Chinese scientist, projecting confidence that the country will be among the first to produce effective inoculation against the coronavirus.